Portfolio

Receptor Biologix

Develops pan-HER ligand traps to treat cancer and other diseases

  • Palo Alto, CA

  • Contact:
    Jeff Himawan
  • Formerly Known As: Receptor Biologix
  • Acquisition
  • Acquired by: Symphogen
  • Exit date: January 29, 2009
  • Logo

All content © 2024
Legal Disclaimer | Privacy Notice

Powered by ITVibes